Verapamil metabolites: potential P-glycoprotein-mediated multidrug resistance reversal agents

By Woodland Cindy   Koren Gideon   Wainer Irving W   Batist Gerry   Ito Shinya  

Canadian Journal of Physiology and Pharmacology, Vol. 81, Iss. 8, 2003-08 ,pp. : 800-805

NRC Research Press

Access to resources Recommend Favorite

SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance

By Baranck M.   Bohacova V.   Kvackajova J.   Hudecova S.   Krizanova O.   Breier A.  

European Journal of Pharmaceutical Sciences, Vol. 14, Iss. 1, 2001-08 ,pp. : 29-36

Elsevier

Access to resources Recommend Favorite

Strategies to Overcome or Circumvent P-Glycoprotein Mediated Multidrug Resistance

By  

Current Medicinal Chemistry, Vol. 15, Iss. 5, 2008-02 ,pp. : 470-476

Bentham Science Publishers

Access to resources Recommend Favorite

Relation between MDR1 mRNA levels, resistance factor, and the efficiency of P-glycoprotein-mediated efflux of pirarubicin in multidrug-resistant K562 sublines

By Meesungnoen Jintana   Jay-Gerin Jean-Paul   Mankhetkorn Samlee  

Canadian Journal of Physiology and Pharmacology, Vol. 80, Iss. 11, 2002-11 ,pp. : 1054-1063

NRC Research Press

Access to resources Recommend Favorite

Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P

By Marbeuf-Gueye C.   Salerno M.   Quidu P.   Garnier-Suillerot A.  

European Journal of Pharmacology, Vol. 391, Iss. 3, 2000-03 ,pp. : 207-216

Elsevier

Access to resources Recommend Favorite